hemophilia A therapy (INSERM/DBV)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehemophilia A therapy (INSERM/DBV)
Drug Alias NameFactor VIII (INSERM/DBV)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDbv Technologies SaInserm
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A